Clinical features of adenomyosis in acromegaly

И. В. Станоевич, Larisa Dzeranova, E. A. Kudrina, Svetlana Vorotnikova, Alexander Lutsenko, E.V. Grezina, B.S. Mamkhegova
In: Rossiiskii vestnik akushera-ginekologa · 2018 · vol. 18(2) , pp. 71 · doi:10.17116/rosakush201818271-76 · W2799393301
article OA: bronze CC0
🔓 Open OA copy Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite+body, 2026-06-12 ⓘ

This study investigated the clinical features of adenomyosis in patients with acromegaly.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-12 · read from full text ⓘ

The paper investigated the clinical features of adenomyosis occurring in women with acromegaly, drawing on clinical observation and synthesis of previously described reproductive system changes related to growth hormone and associated endocrine alterations. It reports characteristic gynecologic presentations of adenomyosis within this specific endocrine context, linking symptom patterns to acromegaly-related hormonal milieu described in the literature. A key limitation is that the accessible text emphasizes literature context and does not provide detailed, study-wide methodology or statistical outcome measures. Relevance to endometriosis: adenomyosis is discussed as part of the broader uterine pathology landscape in which endometriosis-related hormonal growth factor pathways are also cited, though the paper’s main focus is adenomyosis in acromegaly.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 4,859 characters · extracted from oa-html · click to expand
The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals. By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution. Search result: 0 Clinical features of adenomyosis in acromegaly Journal: Russian Bulletin of Obstetrician-Gynecologist. 2018;18(2): 71‑76 Read: 1588 times To cite this article: References: - Corson SL. Endometriosis: the enigmatic disease. Essential Medical Information Systems. Canada. 1992;156-187. - Becker C, Gattrell W, Gude K, Singh S. Reevaluating response and failure of medical treatment of endometriosis: a systematic review. Fertility and Sterility. 2017;108:1:125-136. https://doi.org/10.1016/j.fertnstert.2017.05.004 - Adamyan LV, Andreeva EN, Apolikhina IA. Endometriosis: diagnostics, treatment and rehabilitation. 2013;87. (In Russ.) - Ishhenko AI, Kudrina EA. Endometriosis: modern aspects. Moscow: MIA. 2008;3-11. (In Russ.) - Stanoevich IV. Benign hyperplastic diseases of uterus: pathogenesis, diagnostics, treatment and prophylaxis: Avtoref. dis... d-ra med. nauk. Moscow. 2013;48. (In Russ.) - Shklyar AA, Adamyan LV, Kogan EA. Clinical and morphological features of diffuse and nodal form of adenomyosis. Problemy reproduktsii. 2015;21:1:74-79. (In Russ.) https://doi.org/10.17116/repro20152174-79 - Dedov II. Clinical neuroendocrinology. Moscow: UP Print. 2011;343. (In Russ.) - Chang AY, Auchus RJ. Endocrine disturbances affecting reproduction. In Yen and Jaffe’s. 7th ed. Reproductive Endocrinology: Elsevier Inc. 2013;551-564. https://doi.org/10.1016/B978-1-4557-2758-2.00025-1 - Vorotnikova SYu, Pigarova EA, Dzeranova LK. Metabolic effects of growth hormone. Ozhirenie i metabolism. 2011;4:55-59. (In Russ.) - Pronin AV, Kiryushchenkov AP, Mel’nichenko GA. Reproductive system of women with acromegaly. Vestnik reproduktivnogo zdorov’ya. 2011;1:20-23. (In Russ.) - Zaidieva YaZ, Rifatova AV. Acromegaly in women: A gynecologist’s opinion. Rossiiskii vestnik akushera-ginekologa. 2014;14:3:38-42. (In Russ) - Goenka L, George M, Sen M. A peek into the drug development scenario of endometriosis — a systematic review. Biomed Pharmacother. 2017;90:575-585. https://doi.org/10.1016/j.biopha.2017.03.092 - Li J, Peng X, Zeng X, Liu B, Hao Q, Yu X, Zhu L, Hu Q. Estrogen secreted by mesenchymal stem cells necessarily determines their feasibility of therapeutical application. Sci Rep. 2015;19:5:15286. https://doi.org/10.1038/srep15286 - Pontis A, D’Alterio MN, Pirarba S, de Angelis C, Tinelli R, Angioni S. Adenomyosis: a systematic review of medical treatment. Gynecol Endocrinol. 2016;32:9:696-700. https://doi.org/10.1080/09513590.2016.1197200 - Gershtein ES, Kushlinskii NE. Growth factors, their receptors and downstream signaling proteins: from experiment to clinic. In monografy: molecular cancerogenesis. ABV-press. 2016;374-393. (In Russ.) - Merritt MA, Strickler HD, Einstein MH, Yang HP, Sherman ME, Wentzensen N, Brouwer-Visser J, Cossio MJ, Whitney KD, Yu H, Gunter MJ, Huang GS. Insulin/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors. Cancer Causes Control. 2016;27:6:737-748. https://doi.org/10.1007/s10552-016-0751-4 - Evans A, Jamieson SM, Liu DX, Wilson WR, Perry JK. Growth hormone receptor antagonism suppresses tumour regrowth after radiotherapy in an endometrial cancer xenograft model. Cancer Lett. 2016;28:379:1:117-123. https://doi.org/10.1016/j.canlet.2016.05.031 - Zhang H, Gu M, Wang C. The expression of the receptors of estrogen, progesterone, epidermal growth factor and growth hormone in uterine adenomyosis and a comparative study after treatment with androgen. Zhonghua Fu Chan Ke Za Zhi. 1999;34:4:210-213. - Slater M, Cooper M, Murphy CR. Human growth hormone and interleukin-6 are upregulated in endometriosis and endometrioid adenocarcinoma. Acta Histochem. 2006;108:1:13-18. https://doi.org/10.1016/j.acthis.2006.01.004 - Singh S, Chakravarty AA, Manchanda S, Mallik R, Chopra S, Ajmani A, Kulshreshtha B. Effect of octreotide on endometriosis in acromegaly: case report with review of literature. Indian J Endocrinol Metab. 2014;18:2:241-244. https://doi.org/10.4103/2230-8210.129122 - Nagasawa H, Noguchi Y, Mori T, Niki K, Namiki H. Suppression of normal and preneoplastic mammary growth and uterine adenomyosis with reduced growth hormone level in SHN mice given monosodium glutamate neonatally. Eur J Cancer Clin Oncol. 1985;21:12:1547-1551. Email Confirmation An email was sent to [email protected] with a confirmation link. Follow the link from the letter to complete the registration on the site. Email Confirmation We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (14)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK